Dr. Toluwalase Oluwakemi Tofade, MD

Dr. Tofade practices at Medstar Medical Group II in Arlington, Virginia.

Dr. Tofade's NPI, 1669968798, was assigned on July 1, 2018. Dr. Tofade holds Maryland license D0096012.

Dr. Tofade's primary practice is Medstar Medical Group II, at 2000 15th N St, Arlington, VA 22201 in Arlington County. The practice phone is (443) 444-5606.

Dr. Tofade's primary practice is Medstar Medical Group II in Arlington, Virginia. Dr. Tofade is also affiliated with MedStar Georgetown University Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Tofade to 1 more hospital, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tofade practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Tofade's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Tofade is licensed in Maryland.

CMS data shows 913 Medicare services from Dr. Tofade across 7 procedure codes in 2024, for 414 Medicare patients. Medicare paid $87,436 for them.

CMS counts 414 Medicare patients who saw Dr. Tofade in 2024. The largest group is 75 to 84, with 162 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tofade's median patient age at 64, with 59% women.

In 2024, Dr. Tofade wrote 1,032 Medicare Part D claims for 200 patients. 86% of them were for generic drugs. CMS names the drug for 828 of them, across 30 drugs with 11 or more claims each, at $92,697 in total drug cost. In 2023, CMS named 146 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Tofade for performance year 2024, reported as part of a group. Dr. Tofade accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tofade as offering telehealth.

Dmand AI links 8 papers to Dr. Tofade, published from 2021 to 2024. 2022 was the busiest year, with 3. The most frequent topics are Thrombectomy, Anemia and Brain Ischemia. Dr. Tofade has published most often in J Clin Neurosci. Dr. Tofade's most frequent co-authors are Priyank Khandelwal, MD, Taha Nisar, MD and Sara Shapouran, MD.

CMS Open Payments shows 12 general payments to Dr. Tofade from 9 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Biogen, Inc. paid the most, $42.